Biologics and the Treatment of Severe Airway Disease
For severe asthma and airway hyperreactivity, biologics offer targeted treatment—addressing specific inflammatory pathways. These therapies are reshaping the bronchial hyperreactivity market. Within the Bronchial Hyperreactivity Market, biologics are the fastest-growing segment. Geographically, adoption is strongest in advanced markets. Looking ahead, biologics will grow. For...
0 Comments 0 Shares 3 Views 0 Reviews